As of the most recent data, NVCT shows a P/E ratio of -18.31. That is below the sector sector average of 35.43. Scroll down for historical charts and peer comparison views.

The its sector sector average P/E ratio is about 35.43. Nuvectis Pharma is at -18.31, which is lower that average. That is roughly 151.7% below the sector mean. Use the comparison chart on this page to see how NVCT stacks up against individual peers as well.

Investors watch NVCT's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Nuvectis Pharma's latest reading is -18.31. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this p/e ratio page, Stockcircle has Nuvectis Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -18.31) with ownership activity and broader fundamentals.